EP1693080A3 - Appareils et procédés de dispersion de médicaments pulvérulents secs - Google Patents

Appareils et procédés de dispersion de médicaments pulvérulents secs Download PDF

Info

Publication number
EP1693080A3
EP1693080A3 EP06009725A EP06009725A EP1693080A3 EP 1693080 A3 EP1693080 A3 EP 1693080A3 EP 06009725 A EP06009725 A EP 06009725A EP 06009725 A EP06009725 A EP 06009725A EP 1693080 A3 EP1693080 A3 EP 1693080A3
Authority
EP
European Patent Office
Prior art keywords
medicament
aerosolized
chamber
aeroslized
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06009725A
Other languages
German (de)
English (en)
Other versions
EP1693080A2 (fr
Inventor
John S. Patton
Robert M. Platz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nektar Therapeutics
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of EP1693080A2 publication Critical patent/EP1693080A2/fr
Publication of EP1693080A3 publication Critical patent/EP1693080A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A61M16/0063—Compressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0015—Details of inhalators; Constructional features thereof with inhalation check valves located upstream of the dispenser, i.e. not traversed by the product
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0066—Inhalators with dosage or measuring devices with means for varying the dose size
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/008—Electronic counters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/105—Filters
    • A61M16/106—Filters in a path
    • A61M16/107—Filters in a path in the inspiratory path
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073—Syringe, piston type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Spray Control Apparatus (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP06009725A 1991-07-02 1992-07-02 Appareils et procédés de dispersion de médicaments pulvérulents secs Withdrawn EP1693080A3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72491591A 1991-07-02 1991-07-02
EP92914592A EP0592540B1 (fr) 1991-07-02 1992-07-02 Procede et dispositif d'administration de medicaments en aerosol
EP99110369A EP0940154B1 (fr) 1991-07-02 1992-07-02 Dispositif pour administrer des aérosols de médicaments

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP99110369A Division EP0940154B1 (fr) 1991-07-02 1992-07-02 Dispositif pour administrer des aérosols de médicaments

Publications (2)

Publication Number Publication Date
EP1693080A2 EP1693080A2 (fr) 2006-08-23
EP1693080A3 true EP1693080A3 (fr) 2007-07-25

Family

ID=24912427

Family Applications (3)

Application Number Title Priority Date Filing Date
EP92914592A Expired - Lifetime EP0592540B1 (fr) 1991-07-02 1992-07-02 Procede et dispositif d'administration de medicaments en aerosol
EP06009725A Withdrawn EP1693080A3 (fr) 1991-07-02 1992-07-02 Appareils et procédés de dispersion de médicaments pulvérulents secs
EP99110369A Expired - Lifetime EP0940154B1 (fr) 1991-07-02 1992-07-02 Dispositif pour administrer des aérosols de médicaments

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP92914592A Expired - Lifetime EP0592540B1 (fr) 1991-07-02 1992-07-02 Procede et dispositif d'administration de medicaments en aerosol

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP99110369A Expired - Lifetime EP0940154B1 (fr) 1991-07-02 1992-07-02 Dispositif pour administrer des aérosols de médicaments

Country Status (12)

Country Link
US (4) US5458135A (fr)
EP (3) EP0592540B1 (fr)
JP (1) JP3230056B2 (fr)
KR (1) KR100246082B1 (fr)
AT (2) ATE359842T1 (fr)
AU (1) AU662919B2 (fr)
CA (2) CA2112674C (fr)
DE (2) DE69230613T2 (fr)
DK (1) DK0592540T3 (fr)
ES (2) ES2284226T3 (fr)
GR (1) GR3032973T3 (fr)
WO (1) WO1993000951A1 (fr)

Families Citing this family (511)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
ATE359842T1 (de) * 1991-07-02 2007-05-15 Nektar Therapeutics Abgabevorrichtung für nebelförmige medikamente
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
KR100291620B1 (ko) 1992-09-29 2001-10-24 추후제출 부갑상선호르몬의활성단편의폐를통한전달방법
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6794357B1 (en) * 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
CZ295827B6 (cs) 1994-03-07 2005-11-16 Nektar Therapeutics Způsob aerosolizace dávky inzulinu, inzulinový přípravek a jeho použití
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
ATE299892T1 (de) * 1994-05-18 2005-08-15 Nektar Therapeutics Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
EP0682955B1 (fr) * 1994-05-19 2001-09-05 PARI GmbH Spezialisten für effektive Inhalation Dispositif pour sécher et amortir l'écoulement d'aérosols
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
RU2146153C1 (ru) 1994-09-21 2000-03-10 Инхейл Терапьютик Системз Устройство и способ распыления лекарственных средств в виде сухого порошка (варианты)
US5522385A (en) * 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
PL320856A1 (en) 1994-12-22 1997-11-10 Astra Ab Aerosol drug preparations
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5513630A (en) * 1995-03-08 1996-05-07 Century; Theodore J. Powder dispenser
US5603314A (en) * 1995-03-22 1997-02-18 Bono; Michael Aerosol filtration device and inhalation apparatus containing same
US6205999B1 (en) 1995-04-05 2001-03-27 Aerogen, Inc. Methods and apparatus for storing chemical compounds in a portable inhaler
US6427682B1 (en) 1995-04-05 2002-08-06 Aerogen, Inc. Methods and apparatus for aerosolizing a substance
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6165463A (en) 1997-10-16 2000-12-26 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US6019968A (en) * 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
US5881715A (en) * 1995-07-10 1999-03-16 A & D Company, Limited Handy type atomizer
GB2310607A (en) * 1996-02-29 1997-09-03 Norton Healthcare Ltd Spacer device for inhalers
US5875776A (en) * 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
US6189803B1 (en) 1996-05-13 2001-02-20 University Of Seville Fuel injection nozzle and method of use
US6792940B2 (en) * 1996-05-13 2004-09-21 Universidad De Sevilla Device and method for creating aerosols for drug delivery
US6196525B1 (en) 1996-05-13 2001-03-06 Universidad De Sevilla Device and method for fluid aeration via gas forced through a liquid within an orifice of a pressure chamber
US6386463B1 (en) 1996-05-13 2002-05-14 Universidad De Sevilla Fuel injection nozzle and method of use
US6595202B2 (en) 1996-05-13 2003-07-22 Universidad De Sevilla Device and method for creating aerosols for drug delivery
US6197835B1 (en) 1996-05-13 2001-03-06 Universidad De Sevilla Device and method for creating spherical particles of uniform size
US6187214B1 (en) 1996-05-13 2001-02-13 Universidad De Seville Method and device for production of components for microfabrication
US6405936B1 (en) 1996-05-13 2002-06-18 Universidad De Sevilla Stabilized capillary microjet and devices and methods for producing same
US6299145B1 (en) 1996-05-13 2001-10-09 Universidad De Sevilla Device and method for fluid aeration via gas forced through a liquid within an orifice of a pressure chamber
ES2140998B1 (es) 1996-05-13 2000-10-16 Univ Sevilla Procedimiento de atomizacion de liquidos.
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
FR2751553B1 (fr) * 1996-07-23 1999-06-11 Pedrali Franck Procede pour l'amelioration de la diffusion d'un produit bronchodilatateur en spray et appareils le mettant en oeuvre
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
GB2318737B (en) * 1996-10-30 2000-06-14 Bespak Plc Improved inhalers
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6192882B1 (en) 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
CA2212430A1 (fr) * 1997-08-07 1999-02-07 George Volgyesi Appareil inhalateur
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6394085B1 (en) * 1997-09-25 2002-05-28 Norton Healthcare Ltd. Inhaler spacer
US6073629A (en) * 1997-09-25 2000-06-13 Norton Healthcare Ltd. Inhaler spacer
GB9720283D0 (en) * 1997-09-25 1997-11-26 Norton Healthcare Ltd Inhaler spacer
US6293279B1 (en) 1997-09-26 2001-09-25 Trudell Medical International Aerosol medication delivery apparatus and system
US6345617B1 (en) 1997-09-26 2002-02-12 1263152 Ontario Inc. Aerosol medication delivery apparatus and system
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
PE56799A1 (es) 1997-10-10 1999-06-10 Inhale Therapeutic Syst Metodo y aparato para transportar polvo
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
JP2002508232A (ja) 1997-12-17 2002-03-19 ユニバーシィダッド デ セビリヤ 薬剤投与のためのエーロゾルを生成するデバイスおよび方法
US6009869A (en) * 1997-12-29 2000-01-04 Allegiance Corporation Supersonic nozzle nebulizer
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
EP1066074A1 (fr) * 1998-03-16 2001-01-10 Inhale Therapeutic Systems, Inc. Administration d'agents actifs sous forme d'aerosol
US6113078A (en) 1998-03-18 2000-09-05 Lytesyde, Llc Fluid processing method
JP2002507577A (ja) * 1998-03-25 2002-03-12 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ 三量体抗原性ｏ−結合複合糖ペプチド、その製造方法及びその使用
US6257233B1 (en) * 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
NZ508663A (en) 1998-06-12 2003-02-28 Microdose Technologies Inc A dry powder inhaler with a vibrator to deaggregate the powder and feedback control for controlling dosing
US6142146A (en) * 1998-06-12 2000-11-07 Microdose Technologies, Inc. Inhalation device
US6152130A (en) * 1998-06-12 2000-11-28 Microdose Technologies, Inc. Inhalation device with acoustic control
US6062213A (en) * 1998-06-16 2000-05-16 Fuisz Technologies Ltd. Single unit dose inhalation therapy device
DE19851279B4 (de) * 1998-06-17 2006-05-24 GSF - Forschungszentrum für Umwelt und Gesundheit GmbH Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge
US6260549B1 (en) * 1998-06-18 2001-07-17 Clavius Devices, Inc. Breath-activated metered-dose inhaler
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
CN1896231B (zh) * 1998-08-06 2012-09-05 山景药品公司 分离四聚体尿酸氧化酶的方法
SI1119349T1 (sl) 1998-08-18 2008-12-31 Univ California Antagonisti receptorja epidermalnega rastnega faktorja za zdravljenje hipersekrecije sluzi v pljučah
IL126200A0 (en) * 1998-09-14 1999-05-09 Aerotron Medical Instrumentati Nebulizer
UA73924C2 (en) * 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
US6234167B1 (en) 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
US6450189B1 (en) 1998-11-13 2002-09-17 Universidad De Sevilla Method and device for production of components for microfabrication
GB2344533B (en) * 1998-12-11 2000-10-18 Bespak Plc Improvements in or relating to dispensing apparatus
NZ512383A (en) 1998-12-22 2003-05-30 Univ North Carolina Use of osmotic agents in the treatment of airway diseases and for the delivery of airway drugs
US6223744B1 (en) 1999-03-16 2001-05-01 Multi-Vet Ltd. Wearable aerosol delivery apparatus
AU773556B2 (en) 1999-04-05 2004-05-27 Mannkind Corporation Methods for fine powder formation
JP2002541213A (ja) 1999-04-13 2002-12-03 インヘール セラピューティック システムズ， インコーポレイテッド 不妊症の処置のための乾燥粉末処方物の肺投与
DE19917347A1 (de) * 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
SE522908C2 (sv) * 1999-05-10 2004-03-16 Aneo Ab Arrangemang för att kunna tilldela en levande varelse ett anestesialt tillstånd
US6230703B1 (en) * 1999-06-02 2001-05-15 Michael Bono Aerosol inhalation device providing improved aerosol delivery
ES2241611T3 (es) 1999-06-05 2005-11-01 Innovata Biomed Limited Sisstema de suministro de medicamentos.
GB2353222B (en) * 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
US9006175B2 (en) * 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4713798B2 (ja) 1999-06-29 2011-06-29 マンカインド コーポレイション ペプチドおよびタンパク質の薬学的因子の精製および安定化
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
JP4932109B2 (ja) 1999-07-12 2012-05-16 キャプニア インコーポレイテッド 頭痛、鼻炎及び他のありふれた病気を治す方法及び装置
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
DE19942080A1 (de) * 1999-09-03 2001-03-08 Inamed Gmbh Inhaliergerät
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
KR100702878B1 (ko) * 1999-10-29 2007-04-04 넥타르 테라퓨틱스 개선된 분산성을 갖는 건조 분말 조성물
US6367471B1 (en) 1999-11-01 2002-04-09 Sheffield Pharmaceuticals, Inc. Internal vortex mechanism for inhaler device
US20060172017A1 (en) 1999-11-08 2006-08-03 Capnia, Incorporated Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
US20070039615A1 (en) 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
ATE325633T1 (de) 1999-11-08 2006-06-15 Capnia Inc Vorrichtung zur gleichzeitigen verabreichung von gasen und medikamenten
US20010029947A1 (en) 1999-12-17 2001-10-18 Steve Paboojian Receptacles to facilitate the extraction of powders
US20010035184A1 (en) 1999-12-17 2001-11-01 Carlos Schuler Systems and methods for treating packaged powders
SE515473C2 (sv) * 1999-12-21 2001-08-13 Cardia Innovation Ab Förfarande och anordning för att skapa en skyddande atmosfär i en volym
PE20010819A1 (es) * 2000-01-10 2001-09-05 Procter & Gamble Dispositivo para la inhalacion de polvo seco
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
AU3400501A (en) 2000-02-28 2001-09-12 Vectura Ltd Improvements in or relating to the delivery of oral drugs
US6581590B1 (en) 2000-03-21 2003-06-24 Iep Pharmaceutical Devices Inc. Inhalation actuated device
EP1272243B1 (fr) 2000-04-11 2005-10-26 Trudell Medical International Appareil aerosol avec une capacite de pression expiratoire positive
US6748944B1 (en) 2000-05-03 2004-06-15 Dellavecchia Michael Anthony Ultrasonic dosage device and method
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
AU6247901A (en) 2000-05-05 2001-11-20 Ml Laboratories Plc Inhalation chamber
US6328035B1 (en) 2000-05-09 2001-12-11 Iep Pharmaceutical Devices Inc. Pneumatic breath actuated inhaler
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
WO2001087378A2 (fr) * 2000-05-12 2001-11-22 Dura Pharmaceuticals, Inc. Inhalateur a poudre seche a air comprime
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
US20020000225A1 (en) 2000-06-02 2002-01-03 Carlos Schuler Lockout mechanism for aerosol drug delivery devices
US6849259B2 (en) 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
TWI224511B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd De-agglomerator for breath-actuated dry powder inhaler
PE20020066A1 (es) * 2000-06-23 2002-02-23 Norton Healthcare Ltd Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion
US7080644B2 (en) * 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
US7204245B2 (en) * 2000-07-06 2007-04-17 Clinical Technologies, Inc Aerosol enhancement device
US6363932B1 (en) 2000-07-06 2002-04-02 Clinical Technologies, Inc. Aerosol enhancement device
GB2364919A (en) 2000-07-21 2002-02-13 Cambridge Consultants Inhalers
US6902734B2 (en) 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
UA81743C2 (uk) 2000-08-07 2008-02-11 Центокор, Инк. МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
US7288390B2 (en) 2000-08-07 2007-10-30 Centocor, Inc. Anti-dual integrin antibodies, compositions, methods and uses
US6626168B1 (en) * 2000-08-25 2003-09-30 Corey H. Carroll Nebulizing assembly for infants
WO2002055101A2 (fr) 2000-12-21 2002-07-18 Inhale Therapeutic Syst Compositions de recepteur de l'interleukine 4 en poudre stables au stockage
US6491233B2 (en) 2000-12-22 2002-12-10 Chrysalis Technologies Incorporated Vapor driven aerosol generator and method of use thereof
US6799572B2 (en) 2000-12-22 2004-10-05 Chrysalis Technologies Incorporated Disposable aerosol generator system and methods for administering the aerosol
US6701921B2 (en) 2000-12-22 2004-03-09 Chrysalis Technologies Incorporated Aerosol generator having heater in multilayered composite and method of use thereof
US6681998B2 (en) 2000-12-22 2004-01-27 Chrysalis Technologies Incorporated Aerosol generator having inductive heater and method of use thereof
US6501052B2 (en) 2000-12-22 2002-12-31 Chrysalis Technologies Incorporated Aerosol generator having multiple heating zones and methods of use thereof
US6443152B1 (en) * 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
US7377276B2 (en) * 2001-01-31 2008-05-27 United States Of America As Represented By The Secretary Of The Army Automated inhalation toxicology exposure system and method
US6904912B2 (en) * 2001-01-31 2005-06-14 The United States Of America As Represented By The Secretary Of The Army Automated inhalation toxicology exposure system
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
ZA200306564B (en) * 2001-02-26 2004-10-15 Optinose As Nasal devices.
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
US6546927B2 (en) 2001-03-13 2003-04-15 Aerogen, Inc. Methods and apparatus for controlling piezoelectric vibration
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US7905230B2 (en) * 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
WO2002089880A2 (fr) * 2001-05-10 2002-11-14 Vectura Delivery Devices Limited Inhalateurs
US6631291B2 (en) * 2001-05-18 2003-10-07 Instrumentarium Corp. Closed loop drug administration method and apparatus using EEG complexity for control purposes
GB0112888D0 (en) * 2001-05-26 2001-07-18 Innovata Biomed Ltd Device
GB0114033D0 (en) * 2001-06-09 2001-08-01 Innovata Biomed Ltd Process
EP1270012A1 (fr) * 2001-06-21 2003-01-02 Pfizer Products Inc. Utilisation d'insuline administrée par voie pulmonaire pour le traitement du diabète
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US8221329B2 (en) * 2001-07-31 2012-07-17 The United State Of America As Represented By The Secretary Of The Army Inhalation system and method
JP2003062074A (ja) * 2001-08-29 2003-03-04 Tomohiko Hashiba 吸入装置
US6568390B2 (en) 2001-09-21 2003-05-27 Chrysalis Technologies Incorporated Dual capillary fluid vaporizing device
US6640050B2 (en) 2001-09-21 2003-10-28 Chrysalis Technologies Incorporated Fluid vaporizing device having controlled temperature profile heater/capillary tube
AU2002340083A1 (en) * 2001-09-28 2003-04-07 Kurve Technology, Inc Nasal nebulizer
WO2004039826A1 (fr) 2001-11-14 2004-05-13 Centocor, Inc. Anticorps anti-il-6, compositions, methodes et utilisations associees
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US6804458B2 (en) 2001-12-06 2004-10-12 Chrysalis Technologies Incorporated Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
US6681769B2 (en) 2001-12-06 2004-01-27 Crysalis Technologies Incorporated Aerosol generator having a multiple path heater arrangement and method of use thereof
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
US6701922B2 (en) 2001-12-20 2004-03-09 Chrysalis Technologies Incorporated Mouthpiece entrainment airflow control for aerosol generators
AU2002351271A1 (en) * 2001-12-21 2003-07-24 Nektar Therapeutics Capsule package with moisture barrier
US7360536B2 (en) 2002-01-07 2008-04-22 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
US7677467B2 (en) 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
EP1474196B1 (fr) 2002-01-15 2016-08-17 Novartis AG Procedes et systemes de fonctionnement d'un generateur d'aerosol
JP4304077B2 (ja) * 2002-02-13 2009-07-29 イミュノロジー ラボラトリーズ インコーポレイテッド 微生物感染の処置のための組成物および方法
US6651844B2 (en) 2002-02-22 2003-11-25 Schering Corporation Spray dispenser counter
US6705316B2 (en) * 2002-03-11 2004-03-16 Battelle Pulmonary Therapeutics, Inc. Pulmonary dosing system and method
EP1494732B1 (fr) 2002-03-20 2008-01-30 MannKind Corporation Appareil d'inhalation
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
DE60330761D1 (de) 2002-04-19 2010-02-11 3M Innovative Properties Co Abstandstück für die frühzeitige entfernung des nicht-einatembaren anteils eines medizinischen aerosols
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
WO2003090695A2 (fr) 2002-04-25 2003-11-06 Transkaryotic Therapies, Inc. Traitement d'un deficit en alpha-galactosidase a
US20030205226A1 (en) 2002-05-02 2003-11-06 Pre Holding, Inc. Aerosol medication inhalation system
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
WO2003099359A1 (fr) 2002-05-09 2003-12-04 Kurve Technology, Inc. Chambre de dispersion de particules pour nebuliseur nasal
JP4286498B2 (ja) * 2002-05-14 2009-07-01 アクティヴァエロ ゲーエムベーハー エアロゾルを管理するための装置
EP1509259B1 (fr) 2002-05-20 2016-04-20 Novartis AG Appareil de realisation d'aerosol pour traitement medical et procedes correspondants
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7185651B2 (en) * 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
US6941980B2 (en) * 2002-06-27 2005-09-13 Nektar Therapeutics Apparatus and method for filling a receptacle with powder
EP1545608A4 (fr) 2002-06-28 2006-09-13 Centocor Inc Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
US7516741B2 (en) * 2002-12-06 2009-04-14 Novartis Ag Aerosolization apparatus with feedback mechanism
AU2003303036A1 (en) * 2002-12-13 2004-07-09 Pfizer Products Inc. Method of decreasing hepatic glucose output in diabetic patients
WO2004060260A2 (fr) * 2002-12-18 2004-07-22 Glaxo Group Limited Systeme d'administration de medicament dote d'un embout buccal a event
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050236296A1 (en) * 2002-12-30 2005-10-27 Nektar Therapeutics (Formerly Inhale Therapeutic Systems, Inc.) Carry case for aerosolization apparatus
TW200503781A (en) * 2002-12-31 2005-02-01 Nektar Therapeutics Aerosolizable pharmaceutical formulation for fungal infection therapy
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
KR20050095838A (ko) * 2002-12-31 2005-10-04 넥타르 테라퓨틱스 폐 투여용 불용성 활성제를 갖는 약제학적 제형물
US7669596B2 (en) * 2002-12-31 2010-03-02 Novartis Pharma Ag Aerosolization apparatus with rotating capsule
US20050056280A1 (en) * 2002-12-31 2005-03-17 Nektar Therapeutics Receptacle for an aerosolizable pharmaceutical formulation
US20050042170A1 (en) * 2003-02-14 2005-02-24 The Brigham And Women's Hospital, Inc. Method and device for generating mists and medical uses thereof
ES2383367T5 (es) * 2003-04-09 2021-03-31 Novartis Ag Aparato de pulverización en forma de aerosol con protección de entrada de aire
EP1618108A2 (fr) * 2003-04-09 2006-01-25 Biogen Idec MA Inc. Triazolo [1,5-a]pyrimidines et pyrazolo [1,5-a]pyrimidines et procedes de preparation et d'utilisation de celles-ci
WO2004092173A2 (fr) * 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Antagonistes de recepteur d'adenosine a2a
EP1618109A2 (fr) * 2003-04-09 2006-01-25 Biogen Idec MA Inc. Triazolo [1,5-c]pyrimidines et pyrazolo [1,5-c]pyrimidines et procedes de preparation et d'utilisation de celles-ci
US8869794B1 (en) 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
US7285550B2 (en) * 2003-04-09 2007-10-23 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines and methods of making and using the same
SI1615689T1 (sl) 2003-04-09 2016-05-31 Novartis Ag Naprava za aerosolizacijo s poravnalnim vodilom za prebadanje kapsule
US7674791B2 (en) * 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
US7360537B2 (en) * 2003-04-16 2008-04-22 Trudell Medical International Antistatic medication delivery apparatus
EP2322205A1 (fr) 2003-04-18 2011-05-18 Biogen Idec MA Inc. Conjugués polymères de neublastine
CN100379470C (zh) * 2003-06-30 2008-04-09 刘思进 大蒜呼吸器
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
SI1663235T1 (sl) 2003-08-18 2013-12-31 Parion Sciences, Inc. Zaščiteni pirazinoilgvanidinski blokatorji natrijevega kanala
US8001963B2 (en) * 2003-09-05 2011-08-23 Kurve Technology, Inc. Integrated nebulizer and particle dispersion chamber for nasal delivery of medicament to deep nasal cavity and paranasal sinuses
US20070131230A1 (en) * 2003-09-05 2007-06-14 Kurve Technology, Inc. Nasal adapter for the base of the nose
UA89481C2 (uk) 2003-09-30 2010-02-10 Центокор, Инк. Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
US7338171B2 (en) * 2003-10-27 2008-03-04 Jen-Chuen Hsieh Method and apparatus for visual drive control
WO2005040163A1 (fr) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Composes heterocycliques bloquant les effets des produits terminaux avances de glycation
WO2005044226A2 (fr) * 2003-11-04 2005-05-19 Nectar Therapeutics Formulations de lipides pour l'encapsulation de medicaments
WO2005067898A2 (fr) * 2004-01-07 2005-07-28 Nektar Therapeutics Compositions a liberation prolongee amelioree pour la delivrance de proteines pharmaceutiques
ES2584867T3 (es) * 2004-01-12 2016-09-29 Mannkind Corporation Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2
MXPA06008621A (es) * 2004-02-06 2007-03-27 Microdose Technologies Inc Empaque de burbujas para usarse con un dispositivo de inhalacion.
US7107987B2 (en) * 2004-02-10 2006-09-19 Cfd Research Corporation Spacer for delivery of medications from an inhaler to children and breathing impaired patients
EP1713441A2 (fr) * 2004-02-12 2006-10-25 Nektar Therapeutics Poudres antagonistes de l'interleukine-13, particules sechees par pulverisation, et procedes
MXPA06009515A (es) * 2004-02-24 2007-03-26 Microdose Technologies Inc Metodo y aparato para el suministro de medicamentos a base de un chorro sintetico.
CA2554005C (fr) * 2004-02-24 2013-05-28 Microdose Technologies, Inc. Inhalateur a detection de sens d'ecoulement
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
MXPA06011425A (es) * 2004-03-31 2007-03-12 Johnson & Johnson Memiticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos.
GB0407472D0 (en) * 2004-04-01 2004-05-05 Dvm Pharmaceuticals Inc Small animal mask
US7946291B2 (en) 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
EP1744800B1 (fr) 2004-04-21 2016-06-22 Innovata Biomed Limited Inhalateur
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
US7727962B2 (en) * 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7611709B2 (en) * 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US7723306B2 (en) * 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
NZ552047A (en) 2004-06-18 2009-11-27 Nektar Therapeutics Method of treatment of endobronchial infections
MXPA06015220A (es) * 2004-06-21 2007-12-13 Nektar Therapeutics Composiciones comprendiendo anfotericina b, metodos y sistemas.
US8513204B2 (en) * 2004-06-21 2013-08-20 Novartis Ag Compositions comprising amphotericin B, mehods and systems
NZ553263A (en) 2004-07-19 2010-06-25 Biocon Ltd Insulin-oligomer conjugates, formulations and uses thereof
ATE474586T1 (de) * 2004-08-19 2010-08-15 Biogen Idec Inc Neublastin-varianten
KR101241551B1 (ko) * 2004-08-19 2013-03-11 바이오겐 아이덱 엠에이 인코포레이티드 전환 성장 인자 베타 패밀리 단백질의 리폴딩
KR101273120B1 (ko) 2004-08-20 2013-06-13 맨카인드 코포레이션 다이케토피페라진 합성의 촉매 작용
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
US7393662B2 (en) 2004-09-03 2008-07-01 Centocor, Inc. Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
GB0427028D0 (en) * 2004-12-09 2005-01-12 Cambridge Consultants Dry powder inhalers
DE102005016102B3 (de) * 2005-04-08 2006-10-26 Altana Pharma Ag Vorrichtung zur Dosierung und Trockenvernebelung
BRPI0612942A2 (pt) 2005-04-11 2012-10-09 Savient Pharmaceuticals Inc forma variante de oxidase de urato e uso do mesmo
LT3321359T (lt) 2005-04-11 2021-05-10 Horizon Pharma Rheumatology Llc Urato oksidazės variantinės formos ir jų panaudojimas
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) * 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
PE20061324A1 (es) 2005-04-29 2007-01-15 Centocor Inc Anticuerpos anti-il-6, composiciones, metodos y usos
EP1888257A1 (fr) * 2005-05-05 2008-02-20 Pulmatrix, Inc. Generateur d'aerosols a ultra-sons
KR101488403B1 (ko) 2005-05-18 2015-02-04 엠펙스 파마슈티컬즈, 인코포레이티드 에어로졸화된 플루오로퀴놀론 및 이의 용도
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
US9108211B2 (en) 2005-05-25 2015-08-18 Nektar Therapeutics Vibration systems and methods
AU2006265002B2 (en) 2005-06-30 2012-09-20 Centocor, Inc. Anti-IL-23 antibodies, compositions, methods and uses
US8763605B2 (en) 2005-07-20 2014-07-01 Manta Devices, Llc Inhalation device
ES2611307T3 (es) 2005-08-30 2017-05-08 University Of Miami Inmunomodulación de agonistas, antagonistas e inmunotoxinas del receptor del factor de necrosis tumoral 25 (TNFR25)
IN2014DN09128A (fr) 2005-09-14 2015-07-10 Mannkind Corp
WO2007041481A1 (fr) * 2005-09-29 2007-04-12 Biodel, Inc. Preparations d'insuline a action rapide et prolongee
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
AU2006297394B9 (en) * 2005-09-29 2013-09-19 Novartis Ag Receptacles and kits, such as for dry powder packaging
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
JP5096363B2 (ja) 2005-12-16 2012-12-12 ネクター セラピューティックス Ｇｌｐ−１のポリマ複合体
HUE034269T2 (en) 2005-12-29 2018-02-28 Janssen Biotech Inc Human anti-IL-23 antibodies, preparations, methods and applications
US7681569B2 (en) * 2006-01-23 2010-03-23 Lytesyde, Llc Medical liquid processor apparatus and method
US7717096B2 (en) * 2006-01-23 2010-05-18 Lytesyde, Llc Fuel processor apparatus and method
DE102006007495A1 (de) * 2006-02-17 2007-08-23 Siegfried Generics International Ag Dispergiereinheit
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
ES2450065T3 (es) * 2006-03-01 2014-03-21 Biogen Idec Ma Inc. Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF
JP5188991B2 (ja) * 2006-03-03 2013-04-24 エスティーシー．ユーエヌエム 空力弾性分配メカニズムを有するドライパウダー吸入器
EP2001535A1 (fr) 2006-03-21 2008-12-17 Bang & Olufsen Medicom A/S Passage d'écoulement d'inhalateur
EP2007602A4 (fr) * 2006-03-31 2010-09-22 Centocor Ortho Biotech Inc Mimetiques de l'epo humaine a region centrale a charniere, compositions, procedes et utilisations dans la prevention ou le traitement de pathologies relatives a l'intolerance au glucose ou de l'anemie associee a une nephropathie
JP2009532189A (ja) * 2006-04-05 2009-09-10 マイクロドース セラピューテクス，インコーポレイテッド 可変量の薬剤を供給する吸入装置
EP2357015A3 (fr) 2006-04-05 2012-07-25 MicroDose Therapeutx, Inc. Dispositif d'inhalation à doses variables
EP2013225B1 (fr) * 2006-04-12 2014-12-17 Crealta Pharmaceuticals LLC Purification de protéines au moyen d'un tensioactif cationique
JP2009533471A (ja) 2006-04-12 2009-09-17 バイオデル， インコーポレイテッド 即効型および長時間作用型組合せインスリン製剤
CA2654492C (fr) 2006-05-15 2017-06-27 United Therapeutics Corporation Administration de treprostinil utilisant un inhalateur a dose mesuree
FR2901144B1 (fr) * 2006-05-16 2008-12-26 Diffusion Tech Francaise Sarl Appareils generateur d'aerosols medicaux incluant un dispositif d'amelioration de l'efficacite de depot d'aerosol
LT2068889T (lt) 2006-08-10 2020-02-10 Roy C. Levitt Anakinra, naudojama bronchiolito obliteranso sindromo gydymui
CA2698137A1 (fr) 2006-08-30 2008-03-06 Kurve Technology, Inc. Dispositif de generation et de delivrance d'aerosol
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US20080087279A1 (en) * 2006-10-11 2008-04-17 Tieck Catharine Laureen Johnso Metered dose inhaler
US10350399B2 (en) 2006-11-27 2019-07-16 Frank Levy Apparatus and method for producing an enriched medical suspension of carbon dioxide
US10322271B2 (en) 2006-11-27 2019-06-18 Frank Levy Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid
US11185671B2 (en) * 2006-11-27 2021-11-30 Frank Levy Apparatus and process for producing CO2 enriched medical foam
US11833320B2 (en) 2006-11-27 2023-12-05 Frank Levy Apparatus and process for producing CO2 enriched medical foam
UY30820A1 (es) * 2006-12-21 2008-07-03 Centocor Inc Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
US20080163610A1 (en) * 2007-01-05 2008-07-10 Matthew Thomas Baird Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
US8237558B2 (en) 2007-03-30 2012-08-07 University Health Network Hand hygiene compliance system
EP2134307B1 (fr) 2007-03-30 2017-01-25 University Health Network Système de respect des règles d'hygiène des mains
WO2008124522A2 (fr) * 2007-04-04 2008-10-16 Biodel, Inc. Formulations contenant de l'amyline
NZ580947A (en) 2007-05-01 2012-05-25 Biogen Idec Inc Compositions and methods for increasing vascularization
US10293123B2 (en) * 2007-05-23 2019-05-21 Shin Nippon Biomedical Laboratories, Ltd. Test substance administration system for animal experiment
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
JP4916954B2 (ja) * 2007-05-30 2012-04-18 株式会社吉野工業所 吸引式投薬器
AU2008259768B2 (en) * 2007-06-05 2013-08-29 Paka Pulmonary Pharmaceuticals, Inc. Compositions for delivering medicaments into the lungs, uses thereof
WO2008156586A2 (fr) 2007-06-12 2008-12-24 Alkermes, Inc. Perfectionnements à des dispositifs inhalateurs de poudre
CA2691191A1 (fr) * 2007-06-28 2008-12-31 Per Gerde Systeme d'exposition
US11224704B2 (en) 2007-07-06 2022-01-18 Manta Devices, Llc Dose delivery device for inhalation
CN101795723B (zh) 2007-07-06 2013-06-19 蒙塔设备有限公司 用于存储和输送药物的吸入装置
US8181651B2 (en) * 2007-07-24 2012-05-22 Passy-Muir, Inc. Hand powered suction device with mucus trap and suction catheter for tracheostomy tubes
EP2020249A1 (fr) 2007-08-01 2009-02-04 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalateur
US8028674B2 (en) * 2007-08-07 2011-10-04 Lytesyde, Llc Fuel processor apparatus and method
US20110135648A1 (en) * 2007-08-08 2011-06-09 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
CA2694854C (fr) 2007-08-17 2016-09-27 Csl Behring Gmbh Procedes de purification d'alpha-1-antitrypsine et d'apolipoproteine a-i
US20090056716A1 (en) * 2007-09-04 2009-03-05 Atlantic Research Group Llc Cool air inhaler and methods of treatment using same
EP2207890A4 (fr) 2007-10-05 2010-12-15 Barofold Inc Traitement sous haute pression d'interférons agrégés
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
EP2207584A2 (fr) * 2007-10-25 2010-07-21 Novartis Ag Conditionnement de poudres en emballages pour doses unitaires de médicament
DK2082769T3 (en) 2008-01-24 2015-08-31 Vectura Delivery Devices Ltd inhaler
TWI432198B (zh) 2008-02-26 2014-04-01 Parion Sciences Inc 多芳香族鈉通道阻斷劑
US8371294B2 (en) * 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
CN101980743B (zh) * 2008-03-27 2014-04-02 曼金德公司 干燥粉末吸入系统
JP5600098B2 (ja) * 2008-04-09 2014-10-01 レスピデルム コーポレイション 薬剤、医療又は精製された炭酸ガスの分散及び経皮的な投与のための可動な装置
KR101621986B1 (ko) 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN109568740B (zh) 2008-06-13 2022-05-27 曼金德公司 干粉吸入器和用于药物输送的系统
ES2904623T3 (es) 2008-06-20 2022-04-05 Mannkind Corp Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
WO2010008523A1 (fr) 2008-07-13 2010-01-21 Map Pharmaceuticals, Inc. Procédés et appareil pour distribuer un médicament en aérosol
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
MX2011001409A (es) 2008-08-14 2011-03-29 Cephalon Australia Pty Ltd Anticuerpos anti-il-12/il-23.
US20110105383A1 (en) * 2008-09-10 2011-05-05 Magnus Hook Methods and compositions for stimulation of mammalian innate immune resistance to pathogens
EP2344200A2 (fr) * 2008-09-19 2011-07-20 Nektar Therapeutics Peptides thérapeutiques modifiés, procédés pour les préparer et les utiliser
AU2009292643B2 (en) 2008-09-19 2016-02-18 Nektar Therapeutics Polymer conjugates of therapeutic peptides
NZ592717A (en) 2008-10-07 2013-03-28 Mpex Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation
SI2346509T1 (sl) 2008-10-07 2020-08-31 Horizon Orphan Llc Inhalacija levofloksacina za zmanjšanje vnetja pljuč
MX2011004550A (es) 2008-10-31 2011-07-20 Centocor Ortho Biotech Inc Composiciones de de supercóntigos a base de dominios de fibronectina tipo iii, métodos y usos.
CA2744940A1 (fr) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Procedes et compositions pour la delivrance de medicaments aux poumons
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8550074B2 (en) 2009-01-15 2013-10-08 Manta Devices, Llc Delivery device and related methods
JP5873335B2 (ja) 2009-02-12 2016-03-01 ヤンセン バイオテツク，インコーポレーテツド フィブロネクチンｉｉｉ型ドメインに基づくスカフォールド組成物、方法及び使用
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
US8974828B2 (en) 2009-03-18 2015-03-10 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
MX2011010050A (es) 2009-03-25 2011-12-14 Univ Texas Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos.
CA2757500A1 (fr) 2009-04-01 2010-10-07 Promedior, Inc. Administration pulmonaire et nasale d'une substance amyloide p serique
WO2010133294A2 (fr) * 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapteur, dispositif d'inhalation et nébuliseur
EP2432536B1 (fr) * 2009-05-21 2018-07-04 MicroDose Therapeutx, Inc. Système de cassette rotative pour inhalateur de poudre sèche
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
BRPI1012951A2 (pt) 2009-06-09 2016-07-26 Defyrus Inc "administração de interferon para profilaxia ou tratamento de infecção por patôgeno"
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
HUP1200205A3 (en) 2009-06-25 2012-09-28 Savient Pharmaceuticals Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy
US20110000481A1 (en) * 2009-07-01 2011-01-06 Anand Gumaste Nebulizer for infants and respiratory compromised patients
US9180263B2 (en) * 2009-07-01 2015-11-10 Microdose Therapeutx, Inc. Laboratory animal pulmonary dosing device
WO2011008737A2 (fr) 2009-07-13 2011-01-20 The University Of North Carolina At Chapel Hill Particules d'aérosol modifiées et procédés associés
GB0914738D0 (en) * 2009-08-24 2009-09-30 Cambridge Consultants Inhalers
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
WO2011035140A1 (fr) 2009-09-18 2011-03-24 Paka Pulmonary Pharmaceuticals, Inc. Procédés et compositions pour la délivrance de moitiés de contraste aux poumons
EP2496295A1 (fr) 2009-11-03 2012-09-12 MannKind Corporation Appareil et méthode de simulation d'efforts d'inhalation
EP2498848A2 (fr) 2009-11-12 2012-09-19 Stc.Unm Inhalateur pour poudre sèche avec un élément de dispersion par flottement
EP2504013A1 (fr) 2009-11-24 2012-10-03 Gilead Sciences, Inc. Fosfomycine/tobramycine inhalées pour le traitement d'une maladie respiratoire obstructive chronique
WO2011081937A1 (fr) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Composés de type corticostéroïde-bêta-agoniste-antagoniste muscarinique pour applications thérapeutiques
WO2011085022A1 (fr) 2010-01-05 2011-07-14 Microdose Therapeutx, Inc. Dispositif et procédé d'inhalation
AR080154A1 (es) 2010-02-10 2012-03-14 Immunogen Inc Anticuerpos cd20 y su utilizacion
WO2011116293A2 (fr) 2010-03-19 2011-09-22 Manta Devices, Llc Dispositif d'administration et procédés apparentés
GB201006480D0 (en) * 2010-04-19 2010-06-02 Intersurgical Ag Improvements relating to respiratory apparatus
US20130047985A1 (en) * 2010-04-23 2013-02-28 3M Innovative Properties Company Dry powder inhaler assembly and containers
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
UY33372A (es) 2010-05-10 2011-12-30 Gilead Sciences Inc ?análogos de quinolina bi?funcionales, su uso en la manufactura de medicamentos,composiciones que los comprenden y procesos de preparacion?.
EP3323830B1 (fr) 2010-06-19 2023-08-23 Memorial Sloan-Kettering Cancer Center Anticorps anti-gd2
KR20130117755A (ko) 2010-06-21 2013-10-28 맨카인드 코포레이션 건조 분말 약물 운반 시스템 및 방법
PE20130395A1 (es) 2010-06-24 2013-04-10 Gilead Sciences Inc Pirazolo[1,5-a]pirimidinas para tratamiento antiviral
BR112013001553B1 (pt) 2010-07-22 2021-01-12 Gilead Sciences, Inc. compostos antivirais para o tratamento de infecções por paramyxoviridae e composições farmacêuticas que os compreendem
TW201305185A (zh) 2010-09-13 2013-02-01 Gilead Sciences Inc 用於抗病毒治療之２’－氟取代之碳－核苷類似物
WO2012040707A2 (fr) 2010-09-24 2012-03-29 University Of Florida Research Foundation, Inc. Matériaux et procédés d'amélioration de la fonction gastro-intestinale
CA2812414C (fr) 2010-09-29 2020-09-22 Pulmatrix, Inc. Poudres seches a cations metalliques monovalents pour inhalation
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
CA2823628A1 (fr) 2011-01-05 2012-07-12 Hospira, Inc. Sechage par atomisation de la vancomycine
ES2913095T3 (es) 2011-01-31 2022-05-31 Avalyn Pharma Inc Compuestos de pirfenidona y análogos de piridona en aerosol y usos de los mismos
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012154483A1 (fr) 2011-05-06 2012-11-15 Gilead Sciences, Inc. Formulation de fosfomycine/tobramycine sous forme de poudre sèche pour une inhalation
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
WO2012175735A1 (fr) 2011-06-23 2012-12-27 Vib Vzw Inhibiteurs d'a20 pour le traitement d'infections virales respiratoires
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
PT2723176T (pt) 2011-06-27 2017-07-18 Parion Sciences Inc Dipéptido química e metabolicamente estável que possui potente atividade bloqueadora do canal de sódio
CA2827130A1 (fr) * 2011-06-27 2013-01-03 Board Of Regents, The University Of Texas System Formulations pharmaceutiques toroidales
US11103659B2 (en) 2011-07-06 2021-08-31 Manta Devices, Llc Delivery device and related methods
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
GB2496684A (en) * 2011-11-21 2013-05-22 Adi Wallach Breathing biofeedback device optionally comprising inhalable substance dispenser and breathing feedback methods
WO2013114371A1 (fr) 2012-02-01 2013-08-08 Protalix Ltd. Formulation en poudre sèche de dnase i
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
EP3351552B1 (fr) 2012-03-13 2021-05-19 Gilead Sciences, Inc. Analogues de carba-nucléoside 2'-substitués pour traitement antiviral
ES2691083T3 (es) 2012-04-05 2018-11-23 University Of Florida Research Foundation, Inc. Composición para el tratamiento de fibrosis quística y la inducción de secreción de iones
KR102181318B1 (ko) 2012-04-17 2020-11-20 길리애드 사이언시즈, 인코포레이티드 항바이러스 치료를 위한 화합물 및 방법
US9649454B2 (en) 2012-05-03 2017-05-16 Manta Devices, Llc Delivery device and related methods
WO2013175394A1 (fr) * 2012-05-22 2013-11-28 Koninklijke Philips N.V. Système et procédé pour une thérapie par ventilation en pression avec un flux d'air modulé
KR102109223B1 (ko) 2012-05-29 2020-05-11 패리온 사이언스 인코퍼레이티드 안구 건조 및 다른 점막 질환의 치료를 위한 나트륨 채널 차단제 활성을 보유하는 덴드리머 유사 아미노 아미드
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014051504A1 (fr) * 2012-09-25 2014-04-03 Inhalation Sciences Sweden Ab Système d'exposition pour aérosol et interaction de matériau modèle
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
IN2015DN02573A (fr) 2012-10-31 2015-09-11 Galecto Biotech Ab
CN102961809A (zh) * 2012-11-15 2013-03-13 王路维 一种呼吸同步的气体压缩式雾化器装置
ES2619954T3 (es) 2012-12-17 2017-06-27 Parion Sciences, Inc. Derivados de cloropiracinocarboxamida útiles para el tratamiento de enfermedades favorecidas por una hidratación mucosa insuficiente
CA2896686A1 (fr) 2012-12-17 2014-06-26 Parion Sciences, Inc. Composes 3,5-diamino -6-chloro-n-(n- (4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide
BR112015014178A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
US9757529B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
TWI726291B (zh) 2013-01-07 2021-05-01 英屬維爾京群島商遠東超級實驗室有限公司 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
US20160010043A9 (en) * 2013-02-12 2016-01-14 37 Investment, LLC Alcohol Evaporation Consumption Device
KR102060292B1 (ko) 2013-03-11 2019-12-27 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 폐 기능의 개선 및 방사선 유발된 폐 합병증의 예방 및/또는 치료를 위한 물질 및 방법
ES2754388T3 (es) 2013-03-15 2020-04-17 Mannkind Corp Composiciones y métodos de dicetopiperazina microcristalina
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
EP3345643B1 (fr) 2013-03-15 2021-01-06 Chris V. Ciancone Appareil de stockage et d'espacement d'inhalateur
RU2680267C2 (ru) 2013-03-15 2019-02-19 Мемориал Слоан Кеттеринг Кэнсер Сентер Высокоаффинные антитела к gd2
EP2781232A1 (fr) * 2013-03-21 2014-09-24 Ca-Mi S.R.L. Dispositif pour faciliter l'inhalation de produits médicinaux
JP6473738B2 (ja) 2013-04-01 2019-02-20 パルマトリックス，インコーポレイテッド チオトロピウム乾燥粉末
DE102013210511A1 (de) * 2013-06-06 2014-12-11 Heraeus Medical Gmbh Medizininsche Sprühvorrichtung mit Überdruckventil und Verfahren zum Erzeugen eines Sprühkegels
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
EP3024523B1 (fr) 2013-07-22 2018-08-29 Inhalation Sciences Sweden AB Appareil et procédé de génération d'un aérosol
WO2015017728A1 (fr) 2013-07-31 2015-02-05 Windward Pharma, Inc. Composés inhibiteurs de tyrosine kinase en aérosol et leurs utilisations
WO2015021064A1 (fr) 2013-08-05 2015-02-12 Mannkind Corporation Appareil d'insufflation et procédés
EP2868339B1 (fr) * 2013-11-04 2016-10-19 Stamford Devices Limited Système d'administration d'un aérosol
US10092712B2 (en) 2013-11-04 2018-10-09 Stamford Devices Limited Aerosol delivery system
UA119050C2 (uk) 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
AU2015204558B2 (en) 2014-01-10 2020-04-30 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
CN106456628A (zh) 2014-03-19 2017-02-22 无限药品股份有限公司 用于治疗PI3K‑γ介导的障碍的杂环化合物
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015179369A1 (fr) 2014-05-20 2015-11-26 Infinity Pharmaceuticals, Inc. Traitement de maladies pulmonaires ou respiratoires par administration par inhalation d'inhibiteurs de la pi3 kinase
EP3166666B1 (fr) 2014-07-07 2021-01-13 MicroDose Therapeutx, Inc. Dispositif d'inhalation
WO2016014153A1 (fr) * 2014-07-23 2016-01-28 Microdose Therapeutx, Inc. Nébuliseur de poudre sèche
TWI678369B (zh) 2014-07-28 2019-12-01 美商基利科學股份有限公司 用於治療呼吸道合胞病毒感染之噻吩並［３,２-ｄ］嘧啶、呋喃並［３,２-ｄ］嘧啶及吡咯並［３,２-ｄ］嘧啶化合物類
TWI673283B (zh) 2014-08-21 2019-10-01 美商基利科學股份有限公司 ２’－氯胺基嘧啶酮及嘧啶二酮核苷類
WO2016044839A2 (fr) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions et méthodes pour traiter des infections virales par le biais de l'immunité innée stimulée en combinaison avec des composés antiviraux
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
DK3212212T3 (da) 2014-10-31 2020-12-21 Univ Monash Pulverformulering
EP3223809A4 (fr) 2014-11-24 2018-08-15 Entrinsic Health Solutions, Inc. Compositions d'acide aminé pour le traitement de symptômes de maladie
EP3244952A4 (fr) 2015-01-14 2018-11-14 Respira Therapeutics, Inc. Procédés et dispositifs de dispersion de poudre
WO2016115520A1 (fr) 2015-01-16 2016-07-21 The J. David Gladstone Institutes Méthodes de traitement d'une tauopathie
RU2758113C2 (ru) 2015-03-17 2021-10-26 Мемориал Слоан-Кеттеринг Кэнсер Сентер Антитела к muc16 и их применение
CN108602847A (zh) 2015-12-18 2018-09-28 格莱克特生物技术公司 多晶型及方法
MX2018009248A (es) 2016-02-01 2019-01-21 Incarda Therapeutics Inc Combinacion de monitoreo electronico con terapia farmacologica inhalada para manejar arritmias cardiacas incluyendo fibrilacion auricular.
WO2017145046A1 (fr) * 2016-02-25 2017-08-31 Sabic Global Technologies B.V. Chambre de génération d'aérosols de poussière
AU2017296237A1 (en) 2016-07-15 2019-01-03 Poseida Therapeutics, Inc. Chimeric antigen receptors (CARS) specific for MUC1 and methods for their use
MX2019000643A (es) 2016-07-15 2019-06-13 Poseida Therapeutics Inc Receptores de antigenos quimericos y metodos de uso.
MX2019000651A (es) * 2016-07-28 2019-04-01 Chiesi Farm Spa Metodo y sistema para suministro de medicamento en aerosol.
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
JP7267546B2 (ja) 2016-10-04 2023-05-02 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド アミノ酸組成物及びその使用
WO2018071445A1 (fr) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhalateur et ses méthodes d'utilisation
US11826422B2 (en) 2016-11-09 2023-11-28 Board Of Regents, The University Of Texas System Methods and compositions for adaptive immune modulation
CN110267660A (zh) 2016-12-16 2019-09-20 德克萨斯大学系统董事会 含布罗莫结构域蛋白4(brd4)的抑制剂
CA3051484A1 (fr) 2017-01-27 2018-08-02 Memorial Sloan Kettering Cancer Center Molecules bispecifiques de liaison a her2 et cd3
MA47362A (fr) 2017-01-30 2019-12-04 Janssen Biotech Inc Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif
MA47442A (fr) 2017-02-07 2019-12-18 Janssen Biotech Inc Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
CA3060702A1 (fr) 2017-05-10 2018-11-15 Incarda Therapeutics, Inc. Doses unitaires, aerosols, trousses, et methodes pour traiter des affections cardiaques par administration pulmonaire
BR112020012555A2 (pt) 2017-12-20 2020-11-24 Poseida Therapeutics, Inc. composições de vcar e métodos para uso
US20210008305A1 (en) * 2018-03-09 2021-01-14 Health Research, Inc. Induction spacer for inhaler
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
CA3095939C (fr) 2018-04-06 2023-09-26 Frank Levy Appareil et procede de production d'une suspension medicale enrichie
WO2019240881A2 (fr) * 2018-04-23 2019-12-19 Emory University Vip et agonistes de vip, nanoparticules et utilisations associées contre une maladie inflammatoire médiée par des lymphocytes t
EP3790587A4 (fr) 2018-05-11 2022-01-26 Janssen Biotech, Inc. Méthodes de traitement de la dépression à l'aide d'anticorps il-23
US11389433B2 (en) 2018-06-18 2022-07-19 Board Of Regents, The University Of Texas System BRD4 inhibitor treatment of IgE-mediated diseases
TWI729437B (zh) * 2018-07-17 2021-06-01 微邦科技股份有限公司 驅動霧化器的方法與電路系統
WO2020148651A1 (fr) 2019-01-15 2020-07-23 Janssen Biotech, Inc. Compositions d'anticorps anti-tnf et procédés pour le traitement de l'arthrite idiopathique juvénile
EP3914618A1 (fr) 2019-01-23 2021-12-01 Janssen Biotech, Inc. Compositions d'anticorps anti-tnf destinées à être utilisées dans des méthodes de traitement d'arthrite psoriasique
KR20210141998A (ko) 2019-03-14 2021-11-23 얀센 바이오테크 인코포레이티드 항-tnf 항체 조성물의 제조 방법
EP3938391A1 (fr) 2019-03-14 2022-01-19 Janssen Biotech, Inc. Procédés de production de compositions d'anticorps anti-tnf
EP3938390A1 (fr) 2019-03-14 2022-01-19 Janssen Biotech, Inc. Procédés de fabrication pour la production de compositions d'anticorps anti-tnf
JP2022529779A (ja) * 2019-04-18 2022-06-24 グリーンフィールド ジョン 吸入可能な薬剤を送給するための陽圧式吸入器及びその使用方法
BR112021023295A2 (pt) 2019-05-23 2022-02-08 Janssen Biotech Inc Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa
US20220324959A1 (en) 2019-06-03 2022-10-13 Janssen Biotech, Inc. Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
EP3976648A1 (fr) 2019-06-03 2022-04-06 Janssen Biotech, Inc. Compositions d'anticorps anti-tnf et méthodes pour le traitement de l'arthrite psoriasique
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置
US11020384B2 (en) 2019-08-01 2021-06-01 Incarda Therapeutics, Inc. Antiarrhythmic formulation
WO2021028752A1 (fr) 2019-08-15 2021-02-18 Janssen Biotech, Inc. Anticorps anti-tfn pour le traitement du diabète de type i
US11648367B2 (en) * 2019-12-02 2023-05-16 Nathan Christopher Maier Airway inhalant nebulizer device
CN117736207A (zh) 2019-12-24 2024-03-22 卡尔那生物科学株式会社 二酰基甘油激酶调节化合物
WO2021150883A1 (fr) * 2020-01-22 2021-07-29 Virginia Commonwealth University Inhalateur à poudre sèche à jet d'air pour administration rapide d'aérosols pharmaceutiques aux nourrissons
TW202315607A (zh) 2020-02-18 2023-04-16 美商基利科學股份有限公司 抗病毒化合物
EP4106876A1 (fr) 2020-02-18 2022-12-28 Gilead Sciences, Inc. Composés antiviraux
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
CN111214735A (zh) * 2020-03-20 2020-06-02 青岛未来移动医疗科技有限公司 一种雾化器储雾罐
CA3174777A1 (fr) 2020-04-14 2021-10-21 Eric M. Ostertag Compositions et methodes destinees a etre utilisees dans le traitement du cancer
CN115916212A (zh) 2020-04-17 2023-04-04 联合治疗公司 曲前列尼尔用于治疗间质性肺病
WO2021216547A1 (fr) 2020-04-20 2021-10-28 Sorrento Therapeutics, Inc. Administration pulmonaire de polypeptides ace2
WO2021214587A1 (fr) 2020-04-21 2021-10-28 Janssen Biotech, Inc. Agent anti-tnf alpha pour traiter des infections virales
WO2021214588A1 (fr) 2020-04-21 2021-10-28 Janssen Biotech, Inc. Agent anti-tnf alpha pour traiter des infections à coronavirus
CN115698009A (zh) 2020-05-01 2023-02-03 吉利德科学公司 抑制cd73的2,4-二氧代嘧啶化合物
US11033706B1 (en) 2020-05-26 2021-06-15 The Government of the United States of America, as represented by the Secretary of Homeland Security Inverted cylinder hydrostatic ventilator
US11559655B2 (en) 2020-05-26 2023-01-24 The Government of the United States of America, as represented by the Secretary of Homeland Security Dual container hydrostatic ventilator
AU2021315818A1 (en) 2020-07-31 2023-03-23 Pinetree Therapeutics, Inc. Neuropilin and angiotensin converting enzyme 2 fusion peptides for treating viral infections
JP6958950B1 (ja) * 2020-11-27 2021-11-02 ニップファーマ株式会社 吸入補助器
EP4304582A1 (fr) 2021-03-12 2024-01-17 Alvarius Pharmaceuticals Ltd. Compositions et méthodes pour traiter des addictions comprenant de la 5-meo-dmt
DE102021203756A1 (de) 2021-04-15 2022-10-20 WERRTA GmbH Düsen- und Zerstäubungstechnik Inhalationsaktuator und inhalationsvorrichtung
WO2022240897A1 (fr) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Composition pharmaceutique comprenant de la délafloxacine destinée à être administrée dans le poumon
CN113679504B (zh) * 2021-06-21 2023-06-23 国家烟草质量监督检验中心 动物原位吸药设备
AU2022297367A1 (en) 2021-06-23 2023-12-07 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
CA3222439A1 (fr) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Composes modulant les diacylglycerol kinases
WO2022271684A1 (fr) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Composés modulant les diacylglycérol kinases
WO2022271677A1 (fr) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Composés de modulation de la diacylglycérol kinase
WO2023279115A1 (fr) 2021-07-02 2023-01-05 Henry Ford Health System COMPOSITIONS COMPRENANT DE L'ENDOSIDINE 2 POUR RÉDUIRE UNE INFECTION À SARS-CoV-2
EP4367137A1 (fr) 2021-07-09 2024-05-15 Janssen Biotech, Inc. Procédés de fabrication pour produire des compositions d'anticorps anti-tnf
KR20240034218A (ko) 2021-07-09 2024-03-13 얀센 바이오테크 인코포레이티드 항-tnf 항체 조성물을 생산하기 위한 제조 방법
WO2023028364A1 (fr) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Compositions ciblées et leurs utilisations
CN118201941A (zh) 2021-10-29 2024-06-14 吉利德科学公司 Cd73化合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533065A (en) * 1947-03-08 1950-12-05 George V Taplin Micropulverized therapeutic agents
US4649911A (en) * 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
EP0237507A1 (fr) * 1986-03-07 1987-09-16 Aktiebolaget Draco Dispositif d'inhalation de poudre
WO1990007351A1 (fr) * 1989-01-06 1990-07-12 Hans Gernot Schenk Inhalateur oral
WO1990015635A1 (fr) * 1989-06-16 1990-12-27 Huhtamäki Oy Dispositif permettant de realiser une pulverisation plus efficace d'un medicament pris par inhalation

Family Cites Families (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2603216A (en) * 1952-07-15 Powder inhaler
US513189A (en) * 1894-01-23 Powder-blower
US487744A (en) * 1892-12-13 Self-lighting gas-burner
US2570774A (en) * 1947-10-21 1951-10-09 Frank P C Davis Insufflator
US2549303A (en) * 1949-04-20 1951-04-17 Bristol Lab Inc Inhaler for crystalline pencilllin or the like
US2598525A (en) * 1950-04-08 1952-05-27 E & J Mfg Co Automatic positive pressure breathing machine
US3362405A (en) * 1964-04-06 1968-01-09 Hamilton O. Hazel Method and apparatus for admixing gas with solid particles
US3425600A (en) * 1966-08-11 1969-02-04 Abplanalp Robert H Pressurized powder dispensing device
US3809084A (en) * 1970-02-16 1974-05-07 American Cyanamid Co Pressurized portable dispenser
US3812854A (en) * 1972-10-20 1974-05-28 A Michaels Ultrasonic nebulizer
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
GB1479283A (en) * 1973-07-23 1977-07-13 Bespak Industries Ltd Inhaler for powdered medicament
DE2346914C3 (de) * 1973-09-18 1980-10-16 Paul Ritzau Pari-Werk, Gmbh & Co, 8130 Starnberg Inhalator für pulverförmige Substanzen
US4017007A (en) * 1973-12-26 1977-04-12 Ciba-Geigy Corporation Single dose air pressure operated dispenser
FR2257351A1 (en) * 1974-01-11 1975-08-08 Obert Jean Claude Aerosol device for solid vaccines - feed and breaker screws deliver material sideways into blower chamber
IT1016489B (it) * 1974-03-18 1977-05-30 Isf Spa Inalatore
US3967761A (en) * 1974-04-08 1976-07-06 Southwest Research Institute System for injecting particulate material into the combustion chamber of a repetitive combustion coating apparatus
YU41046B (en) * 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
US4005711A (en) * 1975-01-13 1977-02-01 Syntex Puerto Rico, Inc. Inhalation device
US3964483A (en) * 1975-01-13 1976-06-22 Syntex Puerto Rico, Inc. Inhalation device
FR2299011A1 (fr) * 1975-01-29 1976-08-27 Obert Jean Claude Generateur d'aerosols de part
US3991304A (en) * 1975-05-19 1976-11-09 Hillsman Dean Respiratory biofeedback and performance evaluation system
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4022224A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Reduction of superoxide accumulation caused by smoke inhalation
US3994421A (en) * 1975-09-29 1976-11-30 American Cyanamid Company Unitary therapeutic aerosol dispenser
SE408265B (sv) * 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
US4018185A (en) * 1975-12-15 1977-04-19 Coors Container Company Powder feeder pick-up tube
SE411705B (sv) * 1976-11-09 1980-02-04 Draco Ab Anordning for generering av en avskermad, vesentligen drivmedelsfri aerosol
US4109656A (en) * 1977-02-07 1978-08-29 Sybron Corporation Apparatus for use with insufflators
IN148848B (fr) * 1977-03-02 1981-06-27 Abplanalp Robert H
DE2960616D1 (en) * 1978-05-03 1981-11-12 Fisons Plc Inhalation device
US4253468A (en) * 1978-08-14 1981-03-03 Steven Lehmbeck Nebulizer attachment
IT1116047B (it) * 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma
WO1981001243A1 (fr) * 1979-10-30 1981-05-14 Riker Laboratories Inc Dispositif actionne par la respiration pour administrer des medicaments en poudre
GB2063075B (en) * 1979-11-07 1983-11-09 Sterwin Ag Dose indicator for inhalers
US4452239A (en) * 1980-03-25 1984-06-05 Hilal Malem Medical nebulizing apparatus
DE3167567D1 (en) * 1980-06-06 1985-01-17 Fisons Plc Inhalation device for powdered medicaments
DE3023648A1 (de) * 1980-06-24 1982-01-21 Jaeger, Erich, 8700 Würzburg Einrichtung zur untersuchung der atemwege auf reizstoff-ueberempfindlichkeit
ES8206980A1 (es) * 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
US4484577A (en) * 1981-07-23 1984-11-27 Key Pharmaceuticals, Inc. Drug delivery method and inhalation device therefor
US4470412A (en) * 1982-03-19 1984-09-11 Trutek Research, Inc. Inhalation valve
US4823784A (en) * 1982-04-30 1989-04-25 Cadema Medical Products, Inc. Aerosol inhalation apparatus
DE3230760A1 (de) * 1982-08-18 1984-02-23 Siemens AG, 1000 Berlin und 8000 München Abschaltbarer thyristor
US4778054A (en) * 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
WO1985002346A1 (fr) * 1983-11-28 1985-06-06 Vortran Corporation Atomiseur a entrainement par un gaz
US4534343A (en) * 1984-01-27 1985-08-13 Trutek Research, Inc. Metered dose inhaler
DE3429389C1 (de) * 1984-08-09 1986-03-13 Brugger, Inge, geb. Ritzau, 8130 Starnberg Inhalator
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
FI76929C (fi) * 1984-09-25 1989-01-10 Etelae Haemeen Keuhkovammayhdi Inhalationsdoseringsanordning, som aer avsedd foer nogrann dosering av disponerande laekemedel som ges aot andningssjuka i undersoekningsskedet och/eller laekemedel som ges som spray under behandlingen.
NZ209900A (en) 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
FR2575678B1 (fr) * 1985-01-04 1988-06-03 Saint Gobain Vitrage Ejecteur pneumatique de poudre
US4942544A (en) * 1985-02-19 1990-07-17 Kenneth B. McIntosh Medication clock
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
FI81500C (fi) * 1985-05-23 1990-11-12 Etelae Haemeen Keuhkovammayhdi Andningsbehandlingsapparat.
GR861995B (en) * 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
NZ219021A (en) * 1986-01-27 1989-06-28 Gea Farmaceutisk Fabrik As Inhaler: medicine discharged intermittently during each inhalation
US4739754A (en) * 1986-05-06 1988-04-26 Shaner William T Suction resistant inhalator
FR2598918B1 (fr) * 1986-05-23 1988-08-05 Lille Ii Universite Droit Sant Dispositif permettant l'insufflation dans les voies respiratoires d'une poudre radio-opaque a l'etat finement divise
US4926852B1 (en) 1986-06-23 1995-05-23 Univ Johns Hopkins Medication delivery system phase one
US4790305A (en) * 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
DE3636669C2 (de) * 1986-10-28 2001-08-16 Siemens Ag Anordnung zur Zufuhr von Aerosol zu den Luftwegen und/oder Lungen eines Patienten
US4796614A (en) * 1987-02-26 1989-01-10 Trutek Research, Inc. Collapsible inhalation valve
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
IT1217890B (it) 1988-06-22 1990-03-30 Chiesi Farma Spa Dispositivo per l'inalazione di aerosol dosati
US4852561A (en) * 1988-07-27 1989-08-01 Sperry C R Inhalation device
ES2051371T3 (es) 1988-10-04 1994-06-16 Univ Johns Hopkins Inhalador de aerosoles.
US4984158A (en) * 1988-10-14 1991-01-08 Hillsman Dean Metered dose inhaler biofeedback training and evaluation system
IT1228459B (it) * 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
SE466684B (sv) * 1989-03-07 1992-03-23 Draco Ab Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
GB8908647D0 (en) * 1989-04-17 1989-06-01 Glaxo Group Ltd Device
IT1230313B (it) * 1989-07-07 1991-10-18 Somova Spa Inalatore per medicamenti in capsule.
IT1237118B (it) * 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5201308A (en) * 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
US5113855A (en) * 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
DE4004904A1 (de) * 1990-02-16 1990-09-13 Gerhard Brendel Trommel-applikator
US5020527A (en) * 1990-02-20 1991-06-04 Texax-Glynn Corporation Inhaler device with counter/timer means
NZ250988A (en) * 1990-06-14 1995-09-26 Rhone Poulenc Rorer Ltd Powder inhaler: swirling chamber with anti-static walls
IT1243344B (it) * 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
ATE140629T1 (de) * 1990-09-12 1996-08-15 Hans Bisgaard Inhaliervorrichtung
GB9027234D0 (en) * 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
US5099833A (en) * 1991-02-19 1992-03-31 Baxter International Inc. High efficiency nebulizer having a flexible reservoir
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5186164A (en) * 1991-03-15 1993-02-16 Puthalath Raghuprasad Mist inhaler
DE59107894D1 (de) * 1991-03-21 1996-07-11 Ritzau Pari Werk Gmbh Paul Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
GB9106648D0 (en) * 1991-03-28 1991-05-15 Rhone Poulenc Rorer Ltd New inhaler
DE4193534T1 (de) * 1991-04-15 1997-07-24 Leiras Oy Vorrichtung zum Abmessen einer Dosis pulverförmigen Arzneimittels für die Inhalation
IT1248059B (it) * 1991-06-14 1995-01-05 Miat Spa Insufflatore multidose per farmaci in polvere
ATE359842T1 (de) * 1991-07-02 2007-05-15 Nektar Therapeutics Abgabevorrichtung für nebelförmige medikamente
US6681767B1 (en) * 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US5337740A (en) * 1991-08-01 1994-08-16 New England Pharmaceuticals, Inc. Inhalation devices
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US6119688A (en) * 1991-08-26 2000-09-19 3M Innovative Properties Company Powder dispenser
DE4128295A1 (de) * 1991-08-27 1993-03-04 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung fuer fliessfaehige medien
DE4142238A1 (de) * 1991-12-20 1993-06-24 Boehringer Ingelheim Kg Pulverinhalator mit pulvertraeger aus regelmaessigen mikrostrukturen
US5363842A (en) * 1991-12-20 1994-11-15 Circadian, Inc. Intelligent inhaler providing feedback to both patient and medical professional
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
US5186166A (en) * 1992-03-04 1993-02-16 Riggs John H Powder nebulizer apparatus and method of nebulization
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5284133A (en) * 1992-07-23 1994-02-08 Armstrong Pharmaceuticals, Inc. Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
US5349947A (en) * 1993-07-15 1994-09-27 Newhouse Michael T Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
SE9404439D0 (sv) * 1994-12-21 1994-12-21 Astra Ab Inhalation device
US5875776A (en) * 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
WO1997040819A1 (fr) * 1996-04-29 1997-11-06 Dura Pharmaceuticals, Inc. Methode d'inhalation de poudre seche

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533065A (en) * 1947-03-08 1950-12-05 George V Taplin Micropulverized therapeutic agents
US4649911A (en) * 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
EP0237507A1 (fr) * 1986-03-07 1987-09-16 Aktiebolaget Draco Dispositif d'inhalation de poudre
WO1990007351A1 (fr) * 1989-01-06 1990-07-12 Hans Gernot Schenk Inhalateur oral
WO1990015635A1 (fr) * 1989-06-16 1990-12-27 Huhtamäki Oy Dispositif permettant de realiser une pulverisation plus efficace d'un medicament pris par inhalation

Also Published As

Publication number Publication date
AU2309192A (en) 1993-02-11
CA2444415A1 (fr) 1993-01-21
CA2112674C (fr) 2005-10-04
DE69233690T2 (de) 2008-01-24
EP0592540A1 (fr) 1994-04-20
EP0940154B1 (fr) 2007-04-18
KR940701282A (ko) 1994-05-28
GR3032973T3 (en) 2000-07-31
DK0592540T3 (da) 2000-06-26
CA2112674A1 (fr) 1993-01-21
ATE189124T1 (de) 2000-02-15
US5458135A (en) 1995-10-17
US6138668A (en) 2000-10-31
EP0592540B1 (fr) 2000-01-26
DE69230613D1 (de) 2000-03-02
DE69233690D1 (de) 2007-05-31
KR100246082B1 (ko) 2000-04-01
EP1693080A2 (fr) 2006-08-23
EP0940154A2 (fr) 1999-09-08
EP0940154A3 (fr) 1999-09-22
JP3230056B2 (ja) 2001-11-19
EP0592540A4 (fr) 1994-12-07
JPH07501231A (ja) 1995-02-09
ES2141108T3 (es) 2000-03-16
US20050279349A1 (en) 2005-12-22
ATE359842T1 (de) 2007-05-15
AU662919B2 (en) 1995-09-21
ES2284226T3 (es) 2007-11-01
DE69230613T2 (de) 2000-12-28
US5775320A (en) 1998-07-07
WO1993000951A1 (fr) 1993-01-21

Similar Documents

Publication Publication Date Title
EP1693080A3 (fr) Appareils et procédés de dispersion de médicaments pulvérulents secs
EP1576978A3 (fr) Dispositif d'administration de doses reguleés d'insuline par maitrise du volume inhalé total
CA2086415A1 (fr) Inhalateur
IL130512A0 (en) Medicament delivery and packaging
DK0561838T3 (da) Dispenseringsanordning for pulveriseret lægemiddel
FI902706A0 (fi) Laekemedelsinhalator och -formulation.
EP0751795B8 (fr) Methode et appareil pour charger reservoirs de materiau en particules
EP0640354A3 (fr) Inhalateur pour poudres à tourbillon.
CA2039655A1 (fr) Feuille pour contenir un medicament en poudre microfine
MY115688A (en) Pharmaceutical composition for administration by inhalation
GB9606677D0 (en) Process and device
GEP20043259B (en) Device for Delivery of Aerosolized Active Agent to the Lung of a Human Patient
CA2225396A1 (fr) Cartouche de poudre pharmaceutique avec appareil de dosage integre et inhalateur pour medicaments en poudre
AU6934287A (en) Medical dosing device for discharge of atomized medicament for inhalation air
IE40616B1 (en) Apparatus for dispensing dosages of powdered medicaments by inhalation
HUT67534A (en) Medicaments for inhalation and canister suitable for stoning and delivering these medicaments
HU913680D0 (en) Inhaling apparatus, primarily for powdered medicaments
ZA200205167B (en) gamma-IFN liquid-droplet aerosol and method.
AU4823290A (en) Method and apparatus for identifying and/or dispensing medicinal treatment in the form of a substance, such as powder, paste or liquid, to a wild animal
IL101467A (en) Device and method for delivering milk from a woman's breast into a container
JPS57140715A (en) Antitumor agent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 0940154

Country of ref document: EP

Kind code of ref document: P

Ref document number: 0592540

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PLATZ, ROBERT, M.

Inventor name: PATTON, JOHN, S.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PATTON, JOHN, S.

Inventor name: PLATZ, ROBERT, M.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PLATZ, ROBERT, M.

Inventor name: PATTON, JOHN, S.

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NEKTAR THERAPEUTICS

17P Request for examination filed

Effective date: 20071026

17Q First examination report despatched

Effective date: 20071213

AKX Designation fees paid

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110201